Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Nov;10(22):7988-7995.
doi: 10.1002/cam4.4314. Epub 2021 Sep 29.

Diagnostic models for impending death in terminally ill cancer patients: A multicenter cohort study

Affiliations
Multicenter Study

Diagnostic models for impending death in terminally ill cancer patients: A multicenter cohort study

Masanori Mori et al. Cancer Med. 2021 Nov.

Abstract

Background: Accurately predicting impending death is essential for clinicians to clarify goals of care. We aimed to develop diagnostic models to predict death ≤3 days in cancer patients.

Methods: In this multicenter cohort study, we consecutively enrolled advanced cancer patients admitted to 23 inpatient hospices in 2017. Fifteen clinical signs related to impending death were documented daily from the day when the Palliative Performance Scale (PPS) declined to ≤20-14 days later. We conducted recursive partitioning analysis using the entire data set and performed cross-validation to develop the model (prediction of 3-day impending death-decision tree [P3did-DT]). Then, we summed the number of systems (nervous/cardiovascular/respiratory/musculoskeletal), where any sign was present to underpin P3did score (range = 0-4).

Results: Data following PPS ≤20 were obtained from 1396 of 1896 inpatients (74%). The mean age was 73 ± 12 years, and 399 (29%) had gastrointestinal tract cancer. The P3did-DT was based on three variables and had four terminal leaves: urine output (u/o) ≤200 ml/day and decreased response to verbal stimuli, u/o ≤200 ml/day and no decreased response to verbal stimuli, u/o >200 ml/day and Richmond Agitation-Sedation Scale (RASS) ≤-2, and u/o >200 ml/day and RASS ≥-1. The 3-day mortality rates were 80.3%, 53.3%, 39.9%, and 20.6%, respectively (accuracy = 68.3%). In addition, 79.6%, 62.9%, 47.2%, 32.8%, and 17.4% of patients with P3did scores of 4, 3, 2, 1, and 0, respectively, died ≤3 days.

Conclusion: We successfully developed diagnostic models for death ≤3 days. These may further help clinicians predict impending death and help patients/families prepare for their final days.

Keywords: advanced cancer; diagnostic models; impending death; recursive partitioning analysis.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

FIGURE 1
FIGURE 1
A study flow diagram. aPractical reasons included unavailability of researchers on certain days of the week, outside office hours, or because of staff rotations. bData following PPS ≤20 were not obtained if patients’ PPS remained ≥30 and they were discharged alive, or if they developed PPS ≤20 and died on the same day, as death would occur prior to the daily evaluation. PPS, Palliative Performance Scale
FIGURE 2
FIGURE 2
A recursive partitioning model for impending death within 3 days in patients who developed PPS ≤20 during admission at palliative care units: P3did‐DT. The main model included three variables and had two levels and four leaves. The diagnostic accuracy (1 − error rate) was 68.3%. For each node, the number of patients meeting the criteria is documented along with the 3‐day mortality rate. d, day; P3did‐DT, prediction of 3‐day impending death‐decision tree; PPS, Palliative Performance Scale; RASS, Richmond Agitation‐Sedation Scale; u/o, urine output

References

    1. Ruegger J, Hodgkinson S, Field‐Smith A, Ahmedzai SH. guideline c. Care of adults in the last days of life: summary of NICE guidance. BMJ. 2015;351:h6631. - PubMed
    1. National Comprehensive Cancer Network . Palliative care (Version 2.2019). Accessed September 2, 2019. https://www.nccn.org/professionals/physician_gls/default.aspx#supportive
    1. Miyashita M, Sanjo M, Morita T, Hirai K, Uchitomi Y. Good death in cancer care: a nationwide quantitative study. Ann Oncol. 2007;18:1090‐1097. - PubMed
    1. Masterson MP, Slivjak E, Jankauskaite G, et al. Beyond the bucket list: unfinished and business among advanced cancer patients. Psychooncology. 2018;27:2573‐2580. - PMC - PubMed
    1. Hui D, dos Santos R, Chisholm G, et al. Clinical signs of impending death in cancer patients. Oncologist. 2014;19:681‐687. - PMC - PubMed

Publication types